Marabueno, Stella .
HRN: 26-72-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2025
CEFUROXIME 750MG (VIAL)
02/17/2025
02/24/2025
IV
450mg
Q8
BCF Sec. To ARTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: URTIBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes